Search
bacterial conjunctivitis
see conjunctivitis
Classification:
- acute bacterial conjunctivitis
- hyperacute bacterial conjunctivitis due to Neisseria
Etiology:
- Staphylococcus aureus (most common)
- Streptococcus pneumoniae
- Haemophilus
- Pseudomonas in contact lens wearers
Epidemiology:
- highly contagious
- spread by person-to-person contact or through contact with contaminated surfaces
Clinical manifestations:
- acute bacterial conjunctivitis
- most commonly present after several days of symptoms
- unilateral* diffuse conjunctival redness & discharge
- thick yellow or green discharge [2]
- may awaken with eyelids stuck together
- visual blurring that improves with blinking
- overt changes in visual acuity do not occur
- hyperacute bacterial conjunctivitis due to Neisseria
- sudden onset
- profuse purulent discharge
- diffuse bright red conjunctival hemorrhage
- rapid progression to vision loss
* bilateral involvement may occur
Management:
- acute bacterial conjunctivitis
- frequently self-limiting
- antibiotic eye drops is associated with modestly improved rates of clinical & microbiological remission [1]; NNT = 7 [1]
- choice of antibiotic is generally empiric [2]
- trimethoprim-polymyxin B ophthalmic
- fluoroquinolone ophthalmic if patient wears contact lens (Pseudomonas)
- hyperacute bacterial conjunctivitis due to Neisseria
- emergency ophthalmology consult, hospitalization
- both topical & systemic antibiotics indicated
General
conjunctivitis
References
- The NNT: Topical Antibiotics for Clinical Cure of
Bacterial Conjunctivitis
http://www.thennt.com/nnt/topical-antibiotics-for-bacterial-conjunctivitis/
- Sheikh A, Hurwitz B, van Schayck CP, McLean S, Nurmatov U
Antibiotics versus placebo for acute bacterial conjunctivitis.
Cochrane Database Syst Rev. 2012 Sep 12;9:CD001211
PMID: 22972049
- Medical Knowledge Self Assessment Program (MKSAP) 17, 18, 19.
American College of Physicians, Philadelphia 2015, 2018, 2022